Search Results - "Martins, Julian G."

Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses by Block, Geoffrey A, Pergola, Pablo E, Fishbane, Steven, Martins, Julian G, LeWinter, Robin D, Uhlig, Katrin, Neylan, John F, Chertow, Glenn M

“…Abstract Background Among patients with nondialysis-dependent chronic kidney disease (NDD-CKD) and iron-deficiency anemia (IDA), ferric citrate increases…”
Get full text

Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials by Roger, Simon D, Spinowitz, Bruce S, Lerma, Edgar V, Fishbane, Steven, Ash, Stephen R, Martins, Julian G, Quinn, Carol Moreno, Packham, David K

“…Sodium zirconium cyclosilicate (SZC) binds potassium and ammonium in the gastrointestinal tract. In addition to serum potassium reduction, Phase 2 trial data…”
Get full text

Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials by Puri, Basant K, Martins, Julian G

“…Abstract Concerns about growth retardation and unknown effects on long-term brain development with stimulants have prompted interest in polyunsaturated fatty…”
Get full text

EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials by Martins, Julian G

“…BACKGROUND: Epidemiologic and case-control data suggest that increased dietary intake of omega-3 long-chain polyunsaturated fatty acids (ω3 LC-PUFAs) may be of…”
Get full text

A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss by Pereira, Maria J., Lundkvist, Per, Kamble, Prasad G., Lau, Joey, Martins, Julian G., Sjöström, C. David, Schnecke, Volker, Walentinsson, Anna, Johnsson, Eva, Eriksson, Jan W.

“…Introduction The sodium-glucose cotransporter 2 inhibitor dapagliflozin and the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide reduce bodyweight…”
Get full text

A simulated use study outlining differences in handling errors and preference before and after use of currently available recombinant human follicle-stimulating hormone (r-hFSH) pen injectors by Longobardi, Salvatore, Seidler, Anke, Martins, Julian G., Beckers, Francois P.M., MacGillivray, William, D’Hooghe, Thomas

Get full text

Erratum to: Sodium Zirconium Cyclosilicate Increases Serum Bicarbonate Concentrations Among Patients with Hyperkalaemia: Exploratory Analyses from Three Randomized, Multi-Dose, Placebo-Controlled Trials by Roger, Simon D, Spinowitz, Bruce S, Lerma, Edgar V, Fishbane, Steven, Ash, Stephen R, Martins, Julian G, Quinn, Carol Moreno, Packham, David K

Get full text